Senior insider sale
TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$163.7K
57.05K shares
What this filing means
NAGENDRAN SUKUMAR plans to sell 57.05K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $163.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2025ACC: 0001415889-25-022685
Director
Since Sep 2020
57.05K
Shares to sell
$163.7K
Approx. market value
57.05K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.
8/21/2025
57.05KTotal acquired57.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2025 | RSU Award Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer. | 57.05K | — |
| Total | 57.05K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
57.05K
Market value
$163.7K
8/21/2025
Total
Units
57.05K
Value
$163.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2025 | 57.05K | $163.7K | Nasdaq | Planned |
| Total | 57.05K | $163.7K | ||